

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.09498847 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.72345387 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.68483351 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.55498054 |
| 5 | vocalization behavior (GO:0071625) | 5.48459112 |
| 6 | glutamate secretion (GO:0014047) | 5.46295246 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.40478999 |
| 8 | locomotory exploration behavior (GO:0035641) | 5.31663548 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.15341797 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.06783757 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.94336468 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.82711577 |
| 13 | protein localization to synapse (GO:0035418) | 4.82672796 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.74732533 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.65716794 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.56745339 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.51960809 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.46860638 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.41338414 |
| 20 | exploration behavior (GO:0035640) | 4.35410159 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.32846094 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.26722568 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.19708039 |
| 24 | neuron-neuron synaptic transmission (GO:0007270) | 4.14724546 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.14321682 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.14286894 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 4.00903602 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 3.98762159 |
| 29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.96377728 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 3.90876444 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.88433491 |
| 32 | positive regulation of heat generation (GO:0031652) | 3.81357011 |
| 33 | positive regulation of membrane potential (GO:0045838) | 3.74765867 |
| 34 | long-term memory (GO:0007616) | 3.74065993 |
| 35 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71920093 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.71760887 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.71749812 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.71273169 |
| 39 | neurotransmitter transport (GO:0006836) | 3.68924781 |
| 40 | regulation of synaptic plasticity (GO:0048167) | 3.65258011 |
| 41 | proline transport (GO:0015824) | 3.64929137 |
| 42 | long-term synaptic potentiation (GO:0060291) | 3.62973900 |
| 43 | neuron recognition (GO:0008038) | 3.61519518 |
| 44 | response to histamine (GO:0034776) | 3.60806498 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.59514400 |
| 46 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57480102 |
| 47 | positive regulation of synapse maturation (GO:0090129) | 3.55750146 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.51149265 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.50300409 |
| 50 | activation of protein kinase A activity (GO:0034199) | 3.50186508 |
| 51 | cellular potassium ion homeostasis (GO:0030007) | 3.47835069 |
| 52 | regulation of neurotransmitter secretion (GO:0046928) | 3.47491685 |
| 53 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.47108313 |
| 54 | regulation of fever generation (GO:0031620) | 3.41051800 |
| 55 | positive regulation of neurotransmitter transport (GO:0051590) | 3.40464568 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.40071630 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.37708537 |
| 58 | behavioral response to cocaine (GO:0048148) | 3.37240109 |
| 59 | axonal fasciculation (GO:0007413) | 3.35367504 |
| 60 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.34556465 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.33132349 |
| 62 | presynaptic membrane assembly (GO:0097105) | 3.32749137 |
| 63 | postsynaptic membrane organization (GO:0001941) | 3.32551584 |
| 64 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.32291096 |
| 65 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.28579516 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.28157569 |
| 67 | regulation of neurotransmitter transport (GO:0051588) | 3.25982057 |
| 68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.25379764 |
| 69 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24634295 |
| 70 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.21260767 |
| 71 | negative regulation of cell killing (GO:0031342) | 3.21260767 |
| 72 | L-amino acid import (GO:0043092) | 3.20222220 |
| 73 | regulation of heat generation (GO:0031650) | 3.18191663 |
| 74 | neuromuscular process controlling balance (GO:0050885) | 3.16904958 |
| 75 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.15686865 |
| 76 | membrane depolarization (GO:0051899) | 3.15543320 |
| 77 | membrane hyperpolarization (GO:0060081) | 3.14949420 |
| 78 | innervation (GO:0060384) | 3.14228263 |
| 79 | auditory behavior (GO:0031223) | 3.13507610 |
| 80 | prepulse inhibition (GO:0060134) | 3.12493094 |
| 81 | presynaptic membrane organization (GO:0097090) | 3.12177480 |
| 82 | vesicle transport along microtubule (GO:0047496) | 3.11608486 |
| 83 | behavioral fear response (GO:0001662) | 3.11184932 |
| 84 | behavioral defense response (GO:0002209) | 3.11184932 |
| 85 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.10700439 |
| 86 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.09188868 |
| 87 | learning (GO:0007612) | 3.07463210 |
| 88 | regulation of glutamate secretion (GO:0014048) | 3.06247612 |
| 89 | intraspecies interaction between organisms (GO:0051703) | 3.06140447 |
| 90 | social behavior (GO:0035176) | 3.06140447 |
| 91 | regulation of dendritic spine development (GO:0060998) | 3.05166904 |
| 92 | positive regulation of synaptic transmission (GO:0050806) | 3.04948541 |
| 93 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.04624622 |
| 94 | synaptic transmission (GO:0007268) | 3.04191980 |
| 95 | synapse assembly (GO:0007416) | 3.03627628 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.01840014 |
| 97 | regulation of synaptic transmission (GO:0050804) | 3.01007989 |
| 98 | neuromuscular process controlling posture (GO:0050884) | 3.00216891 |
| 99 | membrane depolarization during action potential (GO:0086010) | 2.98382126 |
| 100 | response to auditory stimulus (GO:0010996) | 2.97446216 |
| 101 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.97302088 |
| 102 | mating behavior (GO:0007617) | 2.97292244 |
| 103 | fear response (GO:0042596) | 2.97070528 |
| 104 | chemosensory behavior (GO:0007635) | 2.96379816 |
| 105 | dendritic spine organization (GO:0097061) | 2.94370522 |
| 106 | sodium ion export (GO:0071436) | 2.92952594 |
| 107 | macrophage activation involved in immune response (GO:0002281) | 2.92328260 |
| 108 | regulation of chronic inflammatory response (GO:0002676) | 2.89679459 |
| 109 | positive regulation of dendritic spine development (GO:0060999) | 2.89671450 |
| 110 | detection of calcium ion (GO:0005513) | 2.89666616 |
| 111 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.88398960 |
| 112 | cellular response to ethanol (GO:0071361) | 2.83538726 |
| 113 | interferon-gamma production (GO:0032609) | 2.80419201 |
| 114 | tolerance induction (GO:0002507) | 2.78034562 |
| 115 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.75809827 |
| 116 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73455222 |
| 117 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.70514339 |
| 118 | negative regulation of T cell mediated immunity (GO:0002710) | 2.70266991 |
| 119 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.66267403 |
| 120 | positive regulation of mast cell activation (GO:0033005) | 2.51088292 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.50024938 |
| 122 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.49991330 |
| 123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48987553 |
| 124 | response to peptidoglycan (GO:0032494) | 2.46772756 |
| 125 | amino acid import (GO:0043090) | 2.46760387 |
| 126 | nerve growth factor signaling pathway (GO:0038180) | 2.44575714 |
| 127 | negative regulation of amino acid transport (GO:0051956) | 2.44331964 |
| 128 | cellular response to ATP (GO:0071318) | 2.43636535 |
| 129 | microglial cell activation (GO:0001774) | 2.42200026 |
| 130 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.42162591 |
| 131 | tryptophan catabolic process (GO:0006569) | 2.42013286 |
| 132 | indole-containing compound catabolic process (GO:0042436) | 2.42013286 |
| 133 | indolalkylamine catabolic process (GO:0046218) | 2.42013286 |
| 134 | negative regulation of interleukin-1 production (GO:0032692) | 2.41283673 |
| 135 | cellular response to interleukin-15 (GO:0071350) | 2.41112873 |
| 136 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.40960540 |
| 137 | alanine transport (GO:0032328) | 2.40944112 |
| 138 | response to interleukin-15 (GO:0070672) | 2.40729663 |
| 139 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.38667464 |
| 140 | potassium ion import (GO:0010107) | 2.38190943 |
| 141 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.36623513 |
| 142 | detection of molecule of bacterial origin (GO:0032490) | 2.36538780 |
| 143 | serotonin metabolic process (GO:0042428) | 2.36331853 |
| 144 | macrophage activation (GO:0042116) | 2.34504364 |
| 145 | oligosaccharide catabolic process (GO:0009313) | 2.31799950 |
| 146 | cAMP catabolic process (GO:0006198) | 2.31101902 |
| 147 | negative regulation of interleukin-17 production (GO:0032700) | 2.29587038 |
| 148 | protein K11-linked deubiquitination (GO:0035871) | 2.29095232 |
| 149 | activated T cell proliferation (GO:0050798) | 2.28276157 |
| 150 | positive regulation of mast cell degranulation (GO:0043306) | 2.27055482 |
| 151 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.27055482 |
| 152 | regulation of gamma-delta T cell activation (GO:0046643) | 2.26728330 |
| 153 | phagosome maturation (GO:0090382) | 2.26589687 |
| 154 | cyclic nucleotide catabolic process (GO:0009214) | 2.25283861 |
| 155 | regulation of ARF protein signal transduction (GO:0032012) | 2.24883169 |
| 156 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.24560432 |
| 157 | regulation of mononuclear cell migration (GO:0071675) | 2.23566169 |
| 158 | kynurenine metabolic process (GO:0070189) | 2.22916271 |
| 159 | myeloid leukocyte mediated immunity (GO:0002444) | 2.22466804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.20174010 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75045788 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21394993 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18111527 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11261566 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08590707 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07479166 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95154048 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.84405437 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74563980 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71978554 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71978554 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.66335791 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.63114169 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60179375 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49256186 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49145659 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48920683 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48227145 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46887669 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.38191465 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24932794 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.22512920 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.21078999 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18845045 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12169987 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11707008 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.07344692 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03759566 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.00129120 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00095357 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.99346608 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.97864197 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.94840009 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92880007 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.92097245 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81785957 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81387650 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79914098 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79878805 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77523725 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74744860 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.74348228 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72965828 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71317809 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60067487 |
| 47 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57565760 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52755333 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52050013 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51024122 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46445626 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44375948 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42456092 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42455853 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40916734 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40590698 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39271802 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38937824 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35913794 |
| 60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35144512 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32638737 |
| 62 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31929165 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31864974 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30144449 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29443680 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29114196 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29084479 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27843762 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27700332 |
| 70 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27534139 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27088186 |
| 72 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26978716 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26901683 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25717001 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25348136 |
| 76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24526839 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22954550 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22489740 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22085176 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22058331 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21450572 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21426734 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20129008 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20041462 |
| 85 | AR_19668381_ChIP-Seq_PC3_Human | 1.19476299 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17240285 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16738048 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16674805 |
| 89 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16261531 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14301898 |
| 91 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14145526 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13578624 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13578624 |
| 94 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12691921 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11857267 |
| 96 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11029345 |
| 97 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10723848 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10580153 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10522084 |
| 100 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09893554 |
| 101 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.09874669 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09830557 |
| 103 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09730529 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09632270 |
| 105 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09552230 |
| 106 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08774359 |
| 107 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07314881 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06056785 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05523709 |
| 110 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05273867 |
| 111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04970478 |
| 112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04905104 |
| 113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04684313 |
| 114 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03923074 |
| 115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03005879 |
| 116 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02514712 |
| 117 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02511446 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01583776 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01388113 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00551188 |
| 121 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.00278533 |
| 122 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99650663 |
| 123 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99454852 |
| 124 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98658921 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98348519 |
| 126 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97896790 |
| 127 | JUN_21703547_ChIP-Seq_K562_Human | 0.97453000 |
| 128 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96851375 |
| 129 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95906344 |
| 130 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95884597 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95679015 |
| 132 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95609935 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95107916 |
| 134 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94300144 |
| 135 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92004618 |
| 136 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92004618 |
| 137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89282711 |
| 138 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89274729 |
| 139 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89196487 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88995691 |
| 141 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88890853 |
| 142 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88648189 |
| 143 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88579655 |
| 144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88261403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.34685880 |
| 2 | MP0003880_abnormal_central_pattern | 5.15002099 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.17443533 |
| 4 | MP0004270_analgesia | 3.86621008 |
| 5 | MP0009745_abnormal_behavioral_response | 3.47412384 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.35724413 |
| 7 | MP0002064_seizures | 3.20487318 |
| 8 | MP0003303_peritoneal_inflammation | 3.16221717 |
| 9 | MP0009046_muscle_twitch | 3.08470945 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.04621064 |
| 11 | MP0002822_catalepsy | 2.99412843 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.87908996 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.65064468 |
| 14 | MP0002272_abnormal_nervous_system | 2.61465595 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.60743673 |
| 16 | MP0001486_abnormal_startle_reflex | 2.58796712 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.34385227 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.34321206 |
| 19 | MP0003724_increased_susceptibility_to | 2.32177563 |
| 20 | MP0002736_abnormal_nociception_after | 2.25990869 |
| 21 | MP0006082_CNS_inflammation | 2.25489743 |
| 22 | MP0005671_abnormal_response_to | 2.21238536 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.17418424 |
| 24 | MP0002735_abnormal_chemical_nociception | 2.17397075 |
| 25 | MP0003436_decreased_susceptibility_to | 2.15518686 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.14365074 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 2.09474729 |
| 28 | MP0002733_abnormal_thermal_nociception | 2.06173352 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.98003582 |
| 30 | MP0001984_abnormal_olfaction | 1.96870143 |
| 31 | MP0001970_abnormal_pain_threshold | 1.96710385 |
| 32 | MP0004510_myositis | 1.96475543 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.92608130 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.89891010 |
| 35 | MP0002184_abnormal_innervation | 1.81593660 |
| 36 | MP0005386_behavior/neurological_phenoty | 1.77519034 |
| 37 | MP0004924_abnormal_behavior | 1.77519034 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.76786379 |
| 39 | MP0008569_lethality_at_weaning | 1.76648805 |
| 40 | MP0009785_altered_susceptibility_to | 1.76582114 |
| 41 | MP0000778_abnormal_nervous_system | 1.74975128 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.74498820 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.74296060 |
| 44 | MP0003329_amyloid_beta_deposits | 1.73639286 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.73229260 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.72627830 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.72054431 |
| 48 | MP0004858_abnormal_nervous_system | 1.70532946 |
| 49 | MP0002419_abnormal_innate_immunity | 1.65704770 |
| 50 | MP0009764_decreased_sensitivity_to | 1.65656696 |
| 51 | MP0001529_abnormal_vocalization | 1.58226071 |
| 52 | MP0008877_abnormal_DNA_methylation | 1.57533730 |
| 53 | MP0001800_abnormal_humoral_immune | 1.53279868 |
| 54 | MP0005387_immune_system_phenotype | 1.52546450 |
| 55 | MP0001790_abnormal_immune_system | 1.52546450 |
| 56 | MP0003879_abnormal_hair_cell | 1.51577714 |
| 57 | MP0000955_abnormal_spinal_cord | 1.50879842 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.47107667 |
| 59 | MP0002723_abnormal_immune_serum | 1.46368021 |
| 60 | MP0003787_abnormal_imprinting | 1.45449086 |
| 61 | MP0001905_abnormal_dopamine_level | 1.44575936 |
| 62 | MP0002882_abnormal_neuron_morphology | 1.43727608 |
| 63 | MP0005310_abnormal_salivary_gland | 1.42740014 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.39986639 |
| 65 | MP0003122_maternal_imprinting | 1.39734988 |
| 66 | MP0004885_abnormal_endolymph | 1.39412571 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.37440485 |
| 68 | MP0000685_abnormal_immune_system | 1.36668327 |
| 69 | MP0001188_hyperpigmentation | 1.35622157 |
| 70 | MP0003195_calcinosis | 1.32079136 |
| 71 | MP0001533_abnormal_skeleton_physiology | 1.28954801 |
| 72 | MP0003633_abnormal_nervous_system | 1.28864184 |
| 73 | MP0005025_abnormal_response_to | 1.25486221 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.25386757 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.25044821 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 1.22835082 |
| 77 | MP0002420_abnormal_adaptive_immunity | 1.22026460 |
| 78 | MP0001819_abnormal_immune_cell | 1.22008978 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 1.21513628 |
| 80 | MP0004142_abnormal_muscle_tone | 1.13758438 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.09897922 |
| 82 | MP0002152_abnormal_brain_morphology | 1.09498288 |
| 83 | MP0003631_nervous_system_phenotype | 1.09239173 |
| 84 | MP0005174_abnormal_tail_pigmentation | 1.09049365 |
| 85 | MP0008872_abnormal_physiological_respon | 1.08097199 |
| 86 | MP0000569_abnormal_digit_pigmentation | 1.07049540 |
| 87 | MP0000343_altered_response_to | 1.06528600 |
| 88 | MP0000013_abnormal_adipose_tissue | 1.03877379 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 1.02422615 |
| 90 | MP0002229_neurodegeneration | 1.02024322 |
| 91 | MP0002998_abnormal_bone_remodeling | 1.01005850 |
| 92 | MP0010386_abnormal_urinary_bladder | 1.00817448 |
| 93 | MP0002332_abnormal_exercise_endurance | 1.00584548 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.97449365 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.96768163 |
| 96 | MP0002405_respiratory_system_inflammati | 0.94619051 |
| 97 | MP0000371_diluted_coat_color | 0.93653216 |
| 98 | MP0005394_taste/olfaction_phenotype | 0.93191246 |
| 99 | MP0005499_abnormal_olfactory_system | 0.93191246 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.91499771 |
| 101 | MP0008874_decreased_physiological_sensi | 0.91169822 |
| 102 | MP0009840_abnormal_foam_cell | 0.89829816 |
| 103 | MP0002254_reproductive_system_inflammat | 0.89149325 |
| 104 | MP0003448_altered_tumor_morphology | 0.87267143 |
| 105 | MP0004145_abnormal_muscle_electrophysio | 0.87004267 |
| 106 | MP0004742_abnormal_vestibular_system | 0.86926188 |
| 107 | MP0001177_atelectasis | 0.86718529 |
| 108 | MP0004947_skin_inflammation | 0.83930590 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.82745335 |
| 110 | MP0000751_myopathy | 0.82534083 |
| 111 | MP0005535_abnormal_body_temperature | 0.81265300 |
| 112 | MP0004085_abnormal_heartbeat | 0.80845967 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.80617817 |
| 114 | MP0000716_abnormal_immune_system | 0.79542218 |
| 115 | MP0005166_decreased_susceptibility_to | 0.77940707 |
| 116 | MP0005409_darkened_coat_color | 0.77246009 |
| 117 | MP0003634_abnormal_glial_cell | 0.77225098 |
| 118 | MP0003632_abnormal_nervous_system | 0.75417229 |
| 119 | MP0003646_muscle_fatigue | 0.75040459 |
| 120 | MP0000631_abnormal_neuroendocrine_gland | 0.74897805 |
| 121 | MP0004130_abnormal_muscle_cell | 0.73611349 |
| 122 | MP0003283_abnormal_digestive_organ | 0.73116916 |
| 123 | MP0001348_abnormal_lacrimal_gland | 0.72625936 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.71644074 |
| 125 | MP0008961_abnormal_basal_metabolism | 0.71176300 |
| 126 | MP0000604_amyloidosis | 0.70369931 |
| 127 | MP0002876_abnormal_thyroid_physiology | 0.70253433 |
| 128 | MP0008469_abnormal_protein_level | 0.69795184 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.69365751 |
| 130 | MP0001664_abnormal_digestion | 0.68588111 |
| 131 | MP0002090_abnormal_vision | 0.68471426 |
| 132 | MP0001853_heart_inflammation | 0.67574241 |
| 133 | MP0006072_abnormal_retinal_apoptosis | 0.65303933 |
| 134 | MP0004484_altered_response_of | 0.64989802 |
| 135 | MP0004233_abnormal_muscle_weight | 0.63234663 |
| 136 | MP0003075_altered_response_to | 0.63195889 |
| 137 | MP0004215_abnormal_myocardial_fiber | 0.61200526 |
| 138 | MP0005187_abnormal_penis_morphology | 0.60613080 |
| 139 | MP0001299_abnormal_eye_distance/ | 0.60185864 |
| 140 | MP0000920_abnormal_myelination | 0.57674854 |
| 141 | MP0001943_abnormal_respiration | 0.57339841 |
| 142 | MP0003690_abnormal_glial_cell | 0.57190503 |
| 143 | MP0003861_abnormal_nervous_system | 0.55493884 |
| 144 | MP0005253_abnormal_eye_physiology | 0.55103688 |
| 145 | MP0005623_abnormal_meninges_morphology | 0.55098142 |
| 146 | MP0010769_abnormal_survival | 0.51629425 |
| 147 | MP0004043_abnormal_pH_regulation | 0.51554012 |
| 148 | MP0003137_abnormal_impulse_conducting | 0.51361232 |
| 149 | MP0010770_preweaning_lethality | 0.50756466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.18894259 |
| 2 | Myokymia (HP:0002411) | 6.63240799 |
| 3 | Focal seizures (HP:0007359) | 6.02261896 |
| 4 | Visual hallucinations (HP:0002367) | 5.29758836 |
| 5 | Atonic seizures (HP:0010819) | 5.08238283 |
| 6 | Epileptic encephalopathy (HP:0200134) | 5.07626336 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.94660359 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.94660359 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.94660359 |
| 10 | Febrile seizures (HP:0002373) | 4.62465603 |
| 11 | Absence seizures (HP:0002121) | 4.44397824 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.33184499 |
| 13 | Dialeptic seizures (HP:0011146) | 4.07007917 |
| 14 | Hyperventilation (HP:0002883) | 3.96657697 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.94877060 |
| 16 | Broad-based gait (HP:0002136) | 3.71982761 |
| 17 | Stomatitis (HP:0010280) | 3.70923386 |
| 18 | Action tremor (HP:0002345) | 3.65845083 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.62692858 |
| 20 | Optic neuritis (HP:0100653) | 3.62692858 |
| 21 | Disinhibition (HP:0000734) | 3.47028086 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 3.40923984 |
| 23 | Poor eye contact (HP:0000817) | 3.37725502 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.31555148 |
| 25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.29483486 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.26744782 |
| 27 | Amblyopia (HP:0000646) | 3.20653044 |
| 28 | Depression (HP:0000716) | 3.17492094 |
| 29 | Truncal ataxia (HP:0002078) | 3.16381046 |
| 30 | Orchitis (HP:0100796) | 3.14107272 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 3.13928377 |
| 32 | Ankle clonus (HP:0011448) | 3.13309382 |
| 33 | Dysdiadochokinesis (HP:0002075) | 3.11276429 |
| 34 | Anxiety (HP:0000739) | 3.04088635 |
| 35 | Abnormality of macrophages (HP:0004311) | 3.03489030 |
| 36 | Abnormal social behavior (HP:0012433) | 3.00783775 |
| 37 | Impaired social interactions (HP:0000735) | 3.00783775 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.99364894 |
| 39 | Dysmetria (HP:0001310) | 2.93503689 |
| 40 | Dysostosis multiplex (HP:0000943) | 2.86734279 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.86460951 |
| 42 | Apathy (HP:0000741) | 2.83953381 |
| 43 | Drooling (HP:0002307) | 2.79003957 |
| 44 | Excessive salivation (HP:0003781) | 2.79003957 |
| 45 | Postural instability (HP:0002172) | 2.78762842 |
| 46 | Impaired smooth pursuit (HP:0007772) | 2.77227625 |
| 47 | Papilledema (HP:0001085) | 2.76881172 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.74838774 |
| 49 | T lymphocytopenia (HP:0005403) | 2.74069416 |
| 50 | Abnormal eating behavior (HP:0100738) | 2.71615796 |
| 51 | Myositis (HP:0100614) | 2.69235905 |
| 52 | Diminished motivation (HP:0000745) | 2.68127859 |
| 53 | Genetic anticipation (HP:0003743) | 2.67906068 |
| 54 | Epileptiform EEG discharges (HP:0011182) | 2.65544480 |
| 55 | Neuronal loss in central nervous system (HP:0002529) | 2.65258704 |
| 56 | Limb dystonia (HP:0002451) | 2.62923564 |
| 57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62134491 |
| 58 | Loss of speech (HP:0002371) | 2.61112035 |
| 59 | Recurrent abscess formation (HP:0002722) | 2.59125576 |
| 60 | Scanning speech (HP:0002168) | 2.58646200 |
| 61 | Termporal pattern (HP:0011008) | 2.58128745 |
| 62 | Insidious onset (HP:0003587) | 2.58128745 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.56990843 |
| 64 | Pheochromocytoma (HP:0002666) | 2.55492336 |
| 65 | Urinary urgency (HP:0000012) | 2.55141059 |
| 66 | Hematochezia (HP:0002573) | 2.53965917 |
| 67 | Absent speech (HP:0001344) | 2.52812153 |
| 68 | Progressive inability to walk (HP:0002505) | 2.50353414 |
| 69 | Global brain atrophy (HP:0002283) | 2.50221548 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49941795 |
| 71 | Torticollis (HP:0000473) | 2.48802122 |
| 72 | Mutism (HP:0002300) | 2.47881081 |
| 73 | Abnormality of T cell number (HP:0011839) | 2.47479662 |
| 74 | Agnosia (HP:0010524) | 2.47034903 |
| 75 | Bradykinesia (HP:0002067) | 2.46276294 |
| 76 | Abnormality of the lower motor neuron (HP:0002366) | 2.45823411 |
| 77 | Spastic gait (HP:0002064) | 2.43513323 |
| 78 | Stereotypic behavior (HP:0000733) | 2.40057717 |
| 79 | Focal dystonia (HP:0004373) | 2.39849074 |
| 80 | Hemiparesis (HP:0001269) | 2.37633127 |
| 81 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.36656973 |
| 82 | Dysmetric saccades (HP:0000641) | 2.36376205 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36308038 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36308038 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36308038 |
| 86 | Hypsarrhythmia (HP:0002521) | 2.36009540 |
| 87 | Neurofibrillary tangles (HP:0002185) | 2.31422188 |
| 88 | Diplopia (HP:0000651) | 2.30982355 |
| 89 | Abnormality of binocular vision (HP:0011514) | 2.30982355 |
| 90 | Impaired vibratory sensation (HP:0002495) | 2.30204991 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.29687303 |
| 92 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.29424739 |
| 93 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.29424739 |
| 94 | Inability to walk (HP:0002540) | 2.27650518 |
| 95 | Memory impairment (HP:0002354) | 2.26777963 |
| 96 | Mediastinal lymphadenopathy (HP:0100721) | 2.26735571 |
| 97 | Megalencephaly (HP:0001355) | 2.24949415 |
| 98 | Autoimmune thrombocytopenia (HP:0001973) | 2.24936004 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24907648 |
| 100 | Keratoconjunctivitis sicca (HP:0001097) | 2.24392354 |
| 101 | Abnormality of the corticospinal tract (HP:0002492) | 2.21993342 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.21456270 |
| 103 | Mucopolysacchariduria (HP:0008155) | 2.21456270 |
| 104 | Status epilepticus (HP:0002133) | 2.19068402 |
| 105 | Generalized myoclonic seizures (HP:0002123) | 2.17951777 |
| 106 | Neuroendocrine neoplasm (HP:0100634) | 2.17941920 |
| 107 | Spastic tetraparesis (HP:0001285) | 2.15909037 |
| 108 | Ocular albinism (HP:0001107) | 2.13641291 |
| 109 | Craniofacial dystonia (HP:0012179) | 2.12860434 |
| 110 | Abnormality of the periventricular white matter (HP:0002518) | 2.12154916 |
| 111 | Fetal akinesia sequence (HP:0001989) | 2.11594418 |
| 112 | Intention tremor (HP:0002080) | 2.11550507 |
| 113 | Resting tremor (HP:0002322) | 2.09993341 |
| 114 | Agitation (HP:0000713) | 2.07308216 |
| 115 | Pulmonary infiltrates (HP:0002113) | 2.05971018 |
| 116 | Iris hypopigmentation (HP:0007730) | 2.05255440 |
| 117 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.05230718 |
| 118 | Lower limb muscle weakness (HP:0007340) | 2.04127764 |
| 119 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04100361 |
| 120 | Blue irides (HP:0000635) | 2.01589127 |
| 121 | Protruding tongue (HP:0010808) | 1.99919213 |
| 122 | Macroglossia (HP:0000158) | 1.99885667 |
| 123 | Gait ataxia (HP:0002066) | 1.99882092 |
| 124 | Delusions (HP:0000746) | 1.99461501 |
| 125 | Gait imbalance (HP:0002141) | 1.98864583 |
| 126 | Hemoptysis (HP:0002105) | 1.98736853 |
| 127 | Hemiplegia (HP:0002301) | 1.98560212 |
| 128 | Annular pancreas (HP:0001734) | 1.98437810 |
| 129 | Albinism (HP:0001022) | 1.95397781 |
| 130 | Abnormality of salivation (HP:0100755) | 1.93748790 |
| 131 | Incomplete penetrance (HP:0003829) | 1.92057146 |
| 132 | Polyphagia (HP:0002591) | 1.89575517 |
| 133 | Ventricular fibrillation (HP:0001663) | 1.84750125 |
| 134 | Generalized hypopigmentation of hair (HP:0011358) | 1.83517184 |
| 135 | Central scotoma (HP:0000603) | 1.81982898 |
| 136 | Retinal dysplasia (HP:0007973) | 1.81380277 |
| 137 | Episodic fever (HP:0001954) | 1.80989753 |
| 138 | Specific learning disability (HP:0001328) | 1.80817203 |
| 139 | Psychosis (HP:0000709) | 1.80278831 |
| 140 | Dementia (HP:0000726) | 1.79893020 |
| 141 | Hypoventilation (HP:0002791) | 1.77405197 |
| 142 | Inappropriate behavior (HP:0000719) | 1.77002506 |
| 143 | Thickened helices (HP:0000391) | 1.74324207 |
| 144 | Rigidity (HP:0002063) | 1.73434249 |
| 145 | Hyperthyroidism (HP:0000836) | 1.71379140 |
| 146 | Failure to thrive in infancy (HP:0001531) | 1.69865108 |
| 147 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.69794475 |
| 148 | Rapidly progressive (HP:0003678) | 1.69603459 |
| 149 | Lower limb asymmetry (HP:0100559) | 1.68480434 |
| 150 | Abnormality of saccadic eye movements (HP:0000570) | 1.67423476 |
| 151 | Amyotrophic lateral sclerosis (HP:0007354) | 1.66638162 |
| 152 | Congenital primary aphakia (HP:0007707) | 1.65922799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.59530797 |
| 2 | NTRK3 | 4.37132331 |
| 3 | MAP3K9 | 3.67471203 |
| 4 | MAP3K4 | 3.25396369 |
| 5 | MAP2K7 | 2.82663872 |
| 6 | MINK1 | 2.67408285 |
| 7 | MARK1 | 2.61635962 |
| 8 | DAPK2 | 2.60560689 |
| 9 | RIPK4 | 2.34754873 |
| 10 | CASK | 2.28634260 |
| 11 | MAP3K12 | 2.23988920 |
| 12 | ACVR1B | 2.18055696 |
| 13 | PAK6 | 2.17599200 |
| 14 | TXK | 2.17312388 |
| 15 | MAP2K4 | 2.03587090 |
| 16 | NTRK1 | 2.02955225 |
| 17 | KSR2 | 1.99932868 |
| 18 | MAP3K14 | 1.95064731 |
| 19 | NTRK2 | 1.86038059 |
| 20 | PLK2 | 1.79603787 |
| 21 | PRKD3 | 1.75215925 |
| 22 | DAPK1 | 1.74181068 |
| 23 | GRK7 | 1.73238585 |
| 24 | CAMKK1 | 1.71624503 |
| 25 | PNCK | 1.70423924 |
| 26 | KSR1 | 1.70332766 |
| 27 | ADRBK2 | 1.63547891 |
| 28 | PDK2 | 1.62746211 |
| 29 | CDK19 | 1.61822134 |
| 30 | TAOK3 | 1.59157394 |
| 31 | CDK5 | 1.54278536 |
| 32 | GRK5 | 1.54110726 |
| 33 | ARAF | 1.47286459 |
| 34 | IRAK3 | 1.39099758 |
| 35 | FRK | 1.36862697 |
| 36 | MAP4K2 | 1.28082998 |
| 37 | PRKCG | 1.24243560 |
| 38 | TNIK | 1.24097896 |
| 39 | IRAK4 | 1.23209994 |
| 40 | MAP3K2 | 1.22106994 |
| 41 | CAMKK2 | 1.21835103 |
| 42 | STK38 | 1.19091123 |
| 43 | SIK2 | 1.18938032 |
| 44 | JAK1 | 1.17928806 |
| 45 | IKBKE | 1.13631342 |
| 46 | MAPK13 | 1.13608348 |
| 47 | BLK | 1.11814212 |
| 48 | IRAK2 | 1.10252807 |
| 49 | CAMK2A | 1.08429571 |
| 50 | FES | 1.06917123 |
| 51 | TYK2 | 1.06382149 |
| 52 | CSK | 1.05661367 |
| 53 | PRPF4B | 1.03356516 |
| 54 | BMPR2 | 1.01638241 |
| 55 | UHMK1 | 1.01566814 |
| 56 | MAP3K13 | 1.01470743 |
| 57 | SYK | 1.00750127 |
| 58 | IKBKB | 1.00325272 |
| 59 | LATS2 | 0.96064288 |
| 60 | OXSR1 | 0.95988501 |
| 61 | SGK494 | 0.95896216 |
| 62 | SGK223 | 0.95896216 |
| 63 | TYRO3 | 0.92622369 |
| 64 | CDK18 | 0.92193322 |
| 65 | MAP3K11 | 0.92153182 |
| 66 | IRAK1 | 0.90461138 |
| 67 | CDK14 | 0.90231682 |
| 68 | CAMK2B | 0.88534539 |
| 69 | PTK2B | 0.88483649 |
| 70 | CDK15 | 0.88471470 |
| 71 | MATK | 0.87941894 |
| 72 | MARK3 | 0.83292281 |
| 73 | STK11 | 0.82889344 |
| 74 | RAF1 | 0.82672083 |
| 75 | CAMK1 | 0.81756162 |
| 76 | SGK2 | 0.81726560 |
| 77 | RET | 0.81314939 |
| 78 | CDK11A | 0.76419606 |
| 79 | PAK3 | 0.75950867 |
| 80 | CSNK1G2 | 0.75817404 |
| 81 | DDR2 | 0.75402320 |
| 82 | TAOK1 | 0.75084463 |
| 83 | PHKG1 | 0.73309496 |
| 84 | PHKG2 | 0.73309496 |
| 85 | MAPK12 | 0.73164610 |
| 86 | TGFBR2 | 0.73042907 |
| 87 | PINK1 | 0.72948998 |
| 88 | JAK2 | 0.71188407 |
| 89 | SGK1 | 0.70723149 |
| 90 | PRKCH | 0.68574998 |
| 91 | HCK | 0.67688986 |
| 92 | MOS | 0.66154431 |
| 93 | SGK3 | 0.65867821 |
| 94 | CCNB1 | 0.65563905 |
| 95 | DYRK1A | 0.64588471 |
| 96 | AKT3 | 0.62194890 |
| 97 | JAK3 | 0.61288550 |
| 98 | PDK1 | 0.58657973 |
| 99 | FGR | 0.57130593 |
| 100 | TBK1 | 0.57005455 |
| 101 | SCYL2 | 0.56994159 |
| 102 | PDPK1 | 0.56225083 |
| 103 | MAPK7 | 0.56067798 |
| 104 | BMPR1B | 0.54465313 |
| 105 | PKN1 | 0.54433422 |
| 106 | CAMK2D | 0.53640948 |
| 107 | CHUK | 0.53013636 |
| 108 | LYN | 0.52941425 |
| 109 | LCK | 0.52710344 |
| 110 | FER | 0.52580571 |
| 111 | TEC | 0.52423754 |
| 112 | PRKCE | 0.52369943 |
| 113 | WNK3 | 0.51922285 |
| 114 | MAP2K6 | 0.51047986 |
| 115 | NLK | 0.50421369 |
| 116 | ALK | 0.50238399 |
| 117 | ZAP70 | 0.50156309 |
| 118 | PRKCZ | 0.50136443 |
| 119 | ITK | 0.50116235 |
| 120 | MAP3K1 | 0.49749047 |
| 121 | CAMK2G | 0.49636438 |
| 122 | MARK2 | 0.49457017 |
| 123 | CAMK1D | 0.48415360 |
| 124 | BCR | 0.47730192 |
| 125 | TNK2 | 0.46586534 |
| 126 | RPS6KA3 | 0.46511539 |
| 127 | LMTK2 | 0.46237987 |
| 128 | TRIM28 | 0.46086947 |
| 129 | MAP2K1 | 0.45610721 |
| 130 | WNK1 | 0.44944399 |
| 131 | MAPK10 | 0.43601219 |
| 132 | PRKCQ | 0.43506272 |
| 133 | CAMK1G | 0.43258848 |
| 134 | NME1 | 0.43207109 |
| 135 | NEK6 | 0.41950391 |
| 136 | SIK3 | 0.41477540 |
| 137 | BRAF | 0.40770890 |
| 138 | MAP4K1 | 0.39291330 |
| 139 | FYN | 0.39243600 |
| 140 | DAPK3 | 0.37941203 |
| 141 | CAMK4 | 0.37319911 |
| 142 | MAPKAPK5 | 0.36485374 |
| 143 | ROCK2 | 0.33822651 |
| 144 | ADRBK1 | 0.33377405 |
| 145 | PRKCB | 0.32806633 |
| 146 | MAP3K6 | 0.32779267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.73049620 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.43883000 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.00713095 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.78126223 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.71935881 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.69453693 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68887470 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.62626728 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.54552514 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.52571390 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.31338781 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.18739498 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.18671184 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12662010 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.05955779 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.93628318 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.92071688 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87016136 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82972840 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.82358149 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80015618 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.77764575 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.77022588 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76604423 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.73391443 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.72183979 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.67395534 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63712257 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.62123353 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61796305 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58741378 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.57730123 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.48615761 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.44738293 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43706522 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43455584 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40363684 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38159899 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.36723536 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30603775 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30193912 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27749440 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.27202679 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24718487 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22837067 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22150909 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.21746784 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19593956 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17463022 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17307081 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16290981 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.13188405 |
| 53 | Malaria_Homo sapiens_hsa05144 | 1.12289754 |
| 54 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.11044733 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.08850457 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06701350 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 1.05965132 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05911960 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05265929 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 1.02968532 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02573360 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 1.01902788 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01824377 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 1.00869421 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00524782 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99627089 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99184802 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98767419 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94934250 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.93590308 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93482073 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.93375657 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89302667 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87415591 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.87345874 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85992552 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85150582 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82804413 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81798115 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80525710 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79710571 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78643318 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75061613 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71829840 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.71812227 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71717379 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69953460 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68595482 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.68023981 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66664221 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66259306 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65406451 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64780532 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64256343 |
| 95 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63396099 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63201438 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62745483 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62700249 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61802846 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61308804 |
| 101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60501096 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.58498071 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58051663 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.58021913 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57480703 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56076671 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55307058 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53148272 |
| 109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52407294 |
| 110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52314935 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51759954 |
| 112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50058238 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49890034 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49723677 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48226431 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47320235 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47072507 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47037320 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46376778 |
| 120 | Platelet activation_Homo sapiens_hsa04611 | 0.45690776 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45095595 |
| 122 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42852560 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.41897774 |
| 124 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41544025 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40258919 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.39296265 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38981474 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38523884 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.37999342 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37256673 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37139079 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36799600 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35810009 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35675145 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33792068 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33460432 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33240803 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32686722 |
| 139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30144123 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29224987 |
| 141 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.28691679 |
| 142 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27977916 |
| 143 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.22753392 |
| 144 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22556299 |

